Lymphoma in Australia

Lymphoma incorporates ICD-10 cancer codes C81 (Hodgkin’s disease), C82 (follicular non-Hodgkin’s lymphoma), C83 (diffuse non-Hodgkin’s lymphoma), C84 (peripheral and cutaneous T-cell lymphomas) and C85–C86 (other and unspecified types of non-Hodgkin’s lymphoma).

New cases of lymphoma

Lymphoma was the 6th most commonly diagnosed cancer in Australia in 2013. It is estimated that it will remain the 6th most commonly diagnosed cancer in 2017.

In 2013, there were 5,589 new cases of lymphoma diagnosed in Australia (3,151 males and 2,438 females). In 2017, it is estimated that 6,232 new cases of lymphoma will be diagnosed in Australia (3,574 males and 2,658 females).

In 2013, the age-standardised incidence rate was 22 cases per 100,000 persons (26 for males and 18 for females). In 2017, it is estimated that the age-standardised incidence rate will be 22 cases per 100,000 persons (27 for males and 18 for females). It is expected the incidence rate of lymphoma will generally increase with age for males, and increase with age until 75–79 in females, before decreasing in the older age groups.

In 2017, it is estimated that the risk of an individual being diagnosed with lymphoma by their 85th birthday will be 1 in 36 (1 in 30 males and 1 in 45 females).

The number of new cases of lymphoma diagnosed increased from 1,918 (1,032 males and 886 females) in 1982 to 5,589 in 2013. Over the same period, the age-standardised incidence rate increased from 15 cases per 100,000 persons (17 for males and 13 for females) in 1982 to 22 cases per 100,000 persons in 2013.

Deaths from lymphoma

In 2014, lymphoma was the 9th leading cause of cancer death in Australia. It is estimated that it will become the 12th most common cause of death from cancer in 2017.

In 2014, there were 1,598 deaths from lymphoma in Australia (907 males and 691 females). In 2017, it is estimated that this will decrease to 1,481 deaths (863 males and 618 females).

In 2014, the age-standardised mortality rate was 5.8 deaths per 100,000 persons (7.4 for males and 4.6 for females). In 2017, it is estimated that the age-standardised mortality rate will decrease to 4.9 deaths per 100,000 persons (6.4 for males and 3.7 for females). The mortality rate of lymphoma will generally increase with age.

In 2017, it is estimated that the risk of an individual dying from lymphoma by their 85th birthday will be 1 in 146 (1 in 114 males and 1 in 196 females).

The number of deaths from lymphoma increased from 662 (378 males and 284 females) in 1968 to 1,598 in 2014. Over the same period, the age-standardised mortality rate increased from 7.0 deaths per 100,000 persons (8.5 for males and 5.7 for females) in 1968 to 9.3 deaths per 100,000 persons in 1997 before decreasing to 5.8 deaths per 100,000 in 2014.

Estimated age-specific incidence and mortality rates for lymphoma, by sex, 2017

This line chart presents the estimated age-specific incidence (solid line) and mortality (dashed line) rates of cancer name for males (blue), females (purple) and persons (green) in 2017. The age-specific incidence and mortality rates are shown on the primary (left) y-axis, with 5-year age groups from ages 0–4 to 85+ shown on the x-axis.

Source: AIHW analysis of the Australian Cancer Database and AIHW National Mortality Dataset (see Cancer compendium data source table 1).

Age-standardised incidence rates for lymphoma 1982–2013 and age-standardised mortality rates for lymphoma 1968–2014, by sex

This line chart presents the estimated age-standardised incidence (solid line) and mortality (dashed line) rates (per 100,000) of cancer name for males (blue), females (purple) and persons (green) over the period 1982–2013 for incidence and 1968–2014 for mortality. The age standardised incidence and mortality rates, expressed per 100,000 persons, are shown on the primary (left) y-axis. Years from 1968 to 2014 are presented on the x-axis.

Source: AIHW analysis of the Australian Cancer Database and AIHW National Mortality Dataset (see Cancer compendium data source table 2).

Survival from lymphoma

In 2009–2013, individuals diagnosed with lymphoma had a 76% chance (75% for males and 77% for females) of surviving for 5 years compared to their counterparts in the general Australian population.

Between 1984–1988 and 2009–2013, 5-year relative survival from lymphoma improved from 52% to 76%.

Figure 3: 5-year relative survival from lymphoma, 1983–1987 to 2008–2012

This line chart presents 5-year relative survival at diagnosis for cancer name by males, females and persons over the period 1984–1988 to 2009–2013. The percentage of survival is presented on the y-axis.

Source: AIHW analysis of the Australian Cancer Database and AIHW National Mortality Dataset (see Cancer compendium data source table 3).

Survivorship population for Lymphoma

The survivorship population is measured using prevalence data. Prevalence refers to the number of people alive who have previously been diagnosed with lymphoma.

The prevalence for 1, 5 and 31 years given below are the number of people living with lymphoma cancer at the end of 2012 who had been diagnosed in the preceding 1, 5 and 31 years respectively.

At the end of 2012, there were 5,097 people living who had been diagnosed with lymphoma that year, 20,200 people who had been diagnosed with lymphoma in the previous 5 years (from 2008 to 2012) and 50,750 people who had been diagnosed with lymphoma in the previous 31 years (from 1982 to 2012).